{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:15:28Z","timestamp":1780773328815,"version":"3.54.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"crossref","award":["215490\/Z\/19\/Z"],"award-info":[{"award-number":["215490\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Cellulitis is an acute bacterial infection of the dermis and subcutaneous tissue usually found complicating a wound, ulcer, or dermatosis. This article provides guidelines for the surveillance of cellulitis. The primary objectives of cellulitis surveillance are to (1) monitor trends in rates of infection, (2) describe the demographic and clinical characteristics of patients with cellulitis, (3) estimate the frequency of complications, and (4) describe the risk factors associated with primary and recurrent cellulitis. This article includes case definitions for clinical cellulitis and group A streptococcal cellulitis, based on clinical and laboratory evidence, and case classifications for an initial and recurrent case. It is expected that surveillance for cellulitis will be for all-cause cellulitis, rather than specifically for Strep A cellulitis. Considerations of the type of surveillance are also presented, including identification of data sources and surveillance type. Minimal surveillance necessary for cellulitis is facility-based, passive surveillance. Prospective, active, facility-based surveillance is recommended for estimates of pathogen-specific cellulitis burden. Participant eligibility, surveillance population, and additional surveillance considerations such as active follow-up of cases, the use of International Classification of Disease diagnosis codes, and microbiological sampling of cases are discussed. Finally, the core data elements to be collected on case report forms are presented.<\/jats:p>","DOI":"10.1093\/ofid\/ofac267","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T05:26:17Z","timestamp":1663219577000},"page":"S25-S30","source":"Crossref","is-referenced-by-count":6,"title":["Standardization of Epidemiological Surveillance of Group A Streptococcal Cellulitis"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1142-7697","authenticated-orcid":false,"given":"Kate M","family":"Miller","sequence":"first","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3965-8323","authenticated-orcid":false,"given":"Theresa","family":"Lamagni","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5835-1167","authenticated-orcid":false,"given":"Roderick","family":"Hay","sequence":"additional","affiliation":[{"name":"St John\u2019s Institute of Dermatology, King\u2019s College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W","family":"Cannon","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"},{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health , Boston, Massachusetts , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7585-4743","authenticated-orcid":false,"given":"Michael","family":"Marks","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Faculty of Infectious Diseases, London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"Hospital for Tropical Diseases and Division of Infection and Immunity, University College London Hospitals , London , United Kingdom"},{"name":"Division of Infection and Immunity, University College London , London , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asha C","family":"Bowen","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"},{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital , Nedlands, Western Australia , Australia"},{"name":"Faculty of Health and Medicine, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Kaslow","sequence":"additional","affiliation":[{"name":"PATH , Seattle, Washington , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cherian","sequence":"additional","affiliation":[{"name":"MMGH Consulting , Geneva , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C","family":"Seale","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , London , United Kingdom"},{"name":"London School of Hygiene & Tropical Medicine , London , United Kingdom"},{"name":"University of Warwick , Coventry , United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janessa","family":"Pickering","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica N","family":"Daw","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-8290","authenticated-orcid":false,"given":"Hannah C","family":"Moore","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-9238","authenticated-orcid":false,"given":"Chris","family":"Van Beneden","sequence":"additional","affiliation":[{"name":"CDC Foundation , Atlanta , Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1182-9792","authenticated-orcid":false,"given":"Jonathan R","family":"Carapetis","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"},{"name":"Faculty of Health and Medicine, University of Western Australia , Nedlands, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4334-5351","authenticated-orcid":false,"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia , Nedlands, Western Australia , Australia"},{"name":"Infectious Diseases Department, Fiona Stanley Hospital , Perth, Western Australia , Australia"},{"name":"School of Medicine and Pharmacology, Harry Perkins Research Institute, Fiona Stanley Hospital, University of Western Australia , Perth, Western Australia , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"2022091517140639900_ofac267-B1","volume-title":"Impetigo, erysipelas and cellulitis","author":"Stevens","year":"2016"},{"key":"2022091517140639900_ofac267-B2","first-page":"1194","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases.","author":"Plasternack","year":"2014","edition":"2-Volume Set"},{"key":"2022091517140639900_ofac267-B3","doi-asserted-by":"crossref","first-page":"e001130","DOI":"10.1136\/bmjpo-2021-001130","article-title":"Cellulitis in children: a retrospective single centre study from Australia","volume":"5","author":"Salleo","year":"2021","journal-title":"BMJ Paediatr Open"},{"key":"2022091517140639900_ofac267-B4","volume-title":"Global Burden of Disease Study 2017 (GBD 2017) Results","author":"Global Burden of Disease Collaborative Network","year":"2018"},{"key":"2022091517140639900_ofac267-B5","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/JCM.00422-08","article-title":"Epidemiology of severe streptococcus pyogenes disease in Europe","volume":"46","author":"Lamagni","year":"2008","journal-title":"J Clin Microbiol"},{"key":"2022091517140639900_ofac267-B6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3201\/eid1402.070888","article-title":"Severe streptococcus pyogenes infections, United Kingdom 2003-2004","volume":"14","author":"Lamagni","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"2022091517140639900_ofac267-B7","doi-asserted-by":"crossref","first-page":"565","DOI":"10.5694\/j.1326-5377.2007.tb01054.x","article-title":"The epidemiology of invasive group a streptococcal disease in Victoria, Australia","volume":"186","author":"O\u2019Grady","year":"2007","journal-title":"Med J Aust"},{"key":"2022091517140639900_ofac267-B8","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3201\/eid15\/2.080558","article-title":"Prospective surveillance of invasive group a streptococcal disease, Fiji 2005\u20132007","volume":"15","author":"Steer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2022091517140639900_ofac267-B9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.cmi.2018.01.024","article-title":"Severe lower limb cellulitis: defining the epidemiology and risk factors for primary episodes in a population-based case-control study","volume":"24","author":"Cannon","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2022091517140639900_ofac267-B10","author":"Centers for Disease Control and Prevention"},{"key":"2022091517140639900_ofac267-B11","author":"Secondary Care Analytical Team ND"},{"key":"2022091517140639900_ofac267-B12","doi-asserted-by":"crossref","first-page":"ofx008","DOI":"10.1093\/ofid\/ofx008","article-title":"Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis","volume":"4","author":"Peterson","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2022091517140639900_ofac267-B13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"2022091517140639900_ofac267-B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5070\/D39GN050RR","article-title":"Diagnostic accuracy in patients admitted to hospitals with cellulitis","volume":"17","author":"David","year":"2011","journal-title":"Dermatol Online J"},{"key":"2022091517140639900_ofac267-B15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/jamadermatol.2014.1085","article-title":"The impact of dermatology consultation on diagnostic accuracy and antibiotic use among patients with suspected cellulitis seen at outpatient internal medicine offices: a randomized clinical trial","volume":"150","author":"Arakaki","year":"2014","journal-title":"JAMA Dermatol"},{"key":"2022091517140639900_ofac267-B16","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2133.2011.10275.x","article-title":"Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care","volume":"164","author":"Levell","year":"2011","journal-title":"Br J Dermatol"},{"key":"2022091517140639900_ofac267-B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7861\/clinmedicine.18-2-160","article-title":"Diagnosis and management of cellulitis","volume":"18","author":"Sullivan","year":"2018","journal-title":"Clin Med"},{"key":"2022091517140639900_ofac267-B18","first-page":"CD004299","article-title":"Interventions for cellulitis and erysipelas","volume":"2010","author":"Kilburn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cmi.2018.01.023","article-title":"Epidemiology and risk factors for recurrent severe lower limb cellulitis: a longitudinal cohort study","volume":"24","author":"Cannon","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B20","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/bjd.16235","article-title":"Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey","volume":"178","author":"Smith","year":"2018","journal-title":"Br J Dermatol"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1099\/jmm.0.000191","article-title":"Specific PCR, bacterial culture, serology and pharyngeal sampling to enhance the aetiological diagnosis of cellulitis","volume":"65","author":"Toleman","year":"2016","journal-title":"J Med Microbiol"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B22","first-page":"1679","article-title":"Inability of polymerase chain reaction, pyrosequencing, and culture of infected and uninfected site skin biopsy specimens to identify the cause of cellulitis","volume":"61","author":"Crisp","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B23","first-page":"471","article-title":"Estimating meningitis hospitalization rates for sentinel hospitals conducting surveillance of invasive bacterial vaccine-preventable diseases","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B24","first-page":"163.e1","article-title":"Lower limb cellulitis and its mimics: part I. lower limb cellulitis","volume":"67","author":"Hirschmann","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"2022091517140639900_ofac267-B25","volume-title":"Surveillance tools for meningitis sentinel hospital surveillance: field guide to rapidly estimate the hospital catchment population (denominator) and the annual rate of hospitalisations","author":"Agocs","year":"2015"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B26","first-page":"723","article-title":"Cellulitis: a review of pathogenesis, diagnosis, and management","volume":"105","author":"Rrapi","year":"2021","journal-title":"Med Clin"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/imj.14034","article-title":"Seasonal and regional patterns of lower leg cellulitis in Western Australia","volume":"49","author":"Manning","year":"2019","journal-title":"Intern Med J"},{"issue":"Suppl_1","key":"2022091517140639900_ofac267-B28","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/jac\/dkg466","article-title":"Managing skin and soft tissue infections: expert panel recommendations on key decision points","volume":"52","author":"Eron","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"\u2013","key":"2022091517140639900_ofac267-B29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/jac\/dkq362","article-title":"Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients","volume":"66","author":"Marwick","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/Supplement_1\/S25\/45877060\/ofac267.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/Supplement_1\/S25\/45877060\/ofac267.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T17:15:24Z","timestamp":1663262124000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/9\/Supplement_1\/S25\/6697941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":29,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2022,9,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac267","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,15]]},"published":{"date-parts":[[2022,9,15]]}}}